Digi-Tech Pharma & AI

Overview

Digi-Tech Pharma & AI is a United Kingdom-based pharmaceutical technology conference and expo, not a standalone pharmaceutical manufacturer or software product company. Hosted exclusively by Corvus Global Events, it brings together pharmaceutical and biotechnology professionals, technology providers, healthcare innovators, and regulatory stakeholders to discuss digital transformation in the pharmaceutical value chain. Its recurring agenda covers AI and machine learning, digital drug discovery, clinical trials, data science, informatics, real-world data and evidence, and digital health. The event is notable for its multi-year continuity and shift from online editions to in-person London programming.

History

Digi-Tech Pharma & AI is a recurring pharmaceutical technology conference hosted exclusively by Corvus Global Events. The available event archive identifies editions from at least 2020 through 2027, including the 7th annual conference in 2024. Earlier editions were held online, while later editions were scheduled at Holiday Inn London–Kensington High Street. No reliable public information identifies an individual founder, incorporation date, acquisition, or ownership change for the event brand.

Product Lines

Manufacturing

Not applicable. Digi-Tech Pharma & AI is an event and conference brand rather than a manufacturer of physical products; its conferences are hosted by Corvus Global Events.

Notable Products

• Digi-Tech Pharma & AI Conference - Annual conference and expo focused on digital transformation in pharmaceuticals, including AI, machine learning, informatics, and data science.
• Digital Drug Discovery Program - Conference programming focused on applying artificial intelligence and machine learning to drug discovery, lead-compound design, and target identification.
• Digital Clinical Trials Program - Sessions addressing technology, data, and analytics across clinical-trial design, execution, and evidence generation.
• Digital Health and Real-World Evidence Program - Content covering digital health ecosystems, real-world data and evidence, patient-centric development, and regulatory considerations.

Reputation

The event is positioned as a professional knowledge-exchange and networking forum for pharmaceutical, biotechnology, healthcare, technology, and regulatory audiences. Its recurring editions and stated focus on practical use cases give it relevance as an industry conference rather than as a product brand. Publicly verifiable information is concentrated on event descriptions and schedules, with limited independent evidence available to assess attendee satisfaction, commercial influence, or criticisms.